Associated Papers
Studies on the functional role of UFMylation in cells (Review).
Qin R et al.
Molecular Medicine Reports, 2025
A guide to UFMylation, an emerging posttranslational modification.
Millrine D et al.
The Febs Journal, 2023
Variant of the catalytic cysteine of UFSP2 leads to spondyloepimetaphyseal dysplasia type Di Rocco.
Mattern L et al.
Bone Reports, 2023
A pathogenic UFSP2 variant in an autosomal recessive form of pediatric neurodevelopmental anomalies and epilepsy.
Ni M et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics, 2021
Ribosomal protein RPL26 is the principal target of UFMylation.
Walczak CP et al.
Proceedings of the National Academy of Sciences of the United States of America, 2019
Novel spondyloepimetaphyseal dysplasia due to UFSP2 gene mutation.
Di Rocco M et al.
Clinical Genetics, 2018
Developmental dysplasia of the hip: usefulness of next generation genomic tools for characterizing the underlying genes - a mini review.
Basit S et al.
Clinical Genetics, 2016
Identification of a mutation in the ubiquitin-fold modifier 1-specific peptidase 2 gene, UFSP2, in an extended South African family with Beukes hip dysplasia.
Watson CM et al.
South African Medical Journal = Suid-afrikaanse Tydskrif Vir Geneeskunde, 2015
The ubiquitin-fold modifier 1 (Ufm1) cascade of Caenorhabditis elegans.
Hertel P et al.
The Journal of Biological Chemistry, 2013
Select a paper to view details